EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ethical Tensions in Formalizing Substance Use Disorder as a Chronic Disease: A Health Systems Leadership Perspective

Donna Meadows, Le Khanh Ngan Nguyen, Amanda Lemon, Lisa Diamond, Elizabeth Driver, Ingrid van Kesteren

Healthcare Management Forum · 16.09.2026

DOI: 10.1177/08404704261481985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Healthcare Management Forum, online erschienen am 16.09.2026. Verfasst von Donna Meadows und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Business, Management Science, University of Strathclyde, Glasgow, United Kingdom. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Substance Use Disorder (SUD) is widely recognized as a chronic, relapsing medical condition by major authorities, including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), supported by clinical and neuroscientific evidence. Despite this recognition, health systems often respond through episodic, crisis-driven, or punitive models of care. Like other chronic diseases, SUD unfolds through stability, relapse, and recovery, requiring sustained, coordinated, person-centred care. Formalizing SUD as a chronic disease may reduce stigma, attract resources, normalize treatment, and shift systems away from crisis-oriented responses. However, Chronic Disease Management (CDM) is grounded in principlism, emphasizing autonomy, beneficence, non-maleficence, and justice. When applied to SUD, these principles can conflict. Respecting autonomy may challenge efforts to promote beneficence, while preventing harm can limit individual choice. Commitments to justice may also be constrained by finite resources. The chronic disease framing is double-edged: it can foster hope by emphasizing recovery and long-term support yet may reinforce perceptions of permanence. Equity remains foundational, as housing, income, and trauma shape vulnerability and recovery. Reliance on coercive or mandated treatment raises additional ethical concerns given limited evidence of benefit and potential harm. We argue that formalizing SUD as a chronic disease can strengthen CDM by demanding continuity, humility, proportionality, and care systems for people as they are, not as we wish them to be.

Autor:innen und Institutionen

  • Faculty of Business, Management Science, University of Strathclyde, Glasgow, United Kingdom.
  • Island Health, Victoria, British Columbia, Canada.

Zitieren

APA

Meadows, D., Nguyen, L. K. N., Lemon, A., Diamond, L., Driver, E., & Kesteren, I. V. (2026). Ethical Tensions in Formalizing Substance Use Disorder as a Chronic Disease: A Health Systems Leadership Perspective. Healthcare Management Forum. https://doi.org/10.1177/08404704261481985

Vancouver

Meadows D, Nguyen LKN, Lemon A, Diamond L, Driver E, Kesteren IV. Ethical Tensions in Formalizing Substance Use Disorder as a Chronic Disease: A Health Systems Leadership Perspective. Healthcare Management Forum. 2026. doi:10.1177/08404704261481985

BibTeX
@article{Meadows2026,
  author = {Meadows, Donna and Nguyen, Le Khanh Ngan and Lemon, Amanda and Diamond, Lisa and Driver, Elizabeth and Kesteren, Ingrid van},
  title = {Ethical Tensions in Formalizing Substance Use Disorder as a Chronic Disease: A Health Systems Leadership Perspective},
  journal = {Healthcare Management Forum},
  year = {2026},
  doi = {10.1177/08404704261481985}
}
Kostenlos starten →